Skip to main content

There's Been a Big Improvement in Lung Cancer Survival

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 19, 2024.

By Carole Tanzer Miller HealthDay Reporter

TUESDAY, Nov. 19, 2024 -- More people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows.

"There is more work to do, but I am incredibly optimistic about the future of lung cancer care," said Harold Wimmer, president and CEO of the American Lung Association (ALA), which documents improved survival rates and opportunities to do more in its 2024 "State of Lung Cancer" report.

In the past five years, the lung cancer survival rate has improved 26%, according to the report. It credits deployment of biomarker testing -- which looks for changes in a tumor's DNA -- as a key factor. Biomarker testing can help tailor treatments to individual patients, it points out.

But, the report notes, access to the testing, which is also called molecular, genomic or genetic testing, is uneven. Only 15 states require comprehensive insurance coverage for it, while five more require some insurance plans to include it.

"This year's 'State of Lung Cancer' report provides a path for states and the federal government to take to improve the lives of people living with this devastating disease," Wimmer said in an ALA news release. "Increasing lung cancer screening rates and expanding biomarker testing are enormous opportunities to catch cancer earlier and provide the best treatments for people diagnosed with the disease."

The new report tracks both nationwide and state-by-state screening rates. Last year, 16% of those eligible nationwide were screened for lung cancer, according to the report.

Rhode Island had the nation's best screening rate (28.6%), while Wyoming had the worst (8.6%). The report projects that nearly 235,000 people nationwide will receive a lung cancer diagnosis this year.

Because many patients aren't diagnosed until their lung cancer is in a late stage, when it is less likely to be curable, the five-year survival rate is 28.4%. That's the percentage of patients who were alive five years after their diagnosis.

Massachusetts had the top survival rate, 37.9%. Oklahoma's 22.2% survival rate was the worst.

Nationwide, 27.4% of lung cancers are diagnosed at an early stage, and those have a higher survival rate, at 64%, according to the report. But 43% of cases aren't caught until a late stage. At that point, the survival rate plummets to 9%.

Massachusetts had the best rate of early diagnosis, 34.7%, and Hawaii the worst, 21.1%.

When diagnosed early, before it has spread, lung cancer is often treated with surgery. Nationwide, 20.7% of cases were treated surgically.

Roughly the same percentage of cases -- 20.9% -- were not treated at all. The report said there are many reasons why, but lack of provider or patient knowledge, cancer-related stigma, fatalism after diagnosis or cost should never be a factor.

Nevada had the highest lack-of-treatment rate -- 36.7% -- and Massachusetts, the lowest, 13.2%.

As is the case across health care, the report noted that minorities have worse outcomes than white patients. They are less likely to be diagnosed early or undergo surgery and are more likely to go untreated.

"More must be done to eliminate lung cancer health disparities," the ALA said.

It called on all states to require insurance coverage of biomarker testing.

Sources

  • American Lung Association, news release, Nov. 19, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Read this next

FDA Authorizes First AI Platform for Breast Cancer Prediction

FRIDAY, June 6, 2025 -- The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a...

4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone

FRIDAY, June 6, 2025 — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in...

Long-Lasting HIV Prevention Shot Headed Toward Approval

FRIDAY, June 6, 2025 — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.